russjcardiolРоссийский кардиологический журналRussian Journal of Cardiology1560-40712618-7620«SILICEA-POLIGRAF» LLC10.15829/1560-4071-2015-4-111-117russjcardiol-296Research ArticleОБЗОРЫ ЛИТЕРАТУРЫREVIEWОЖИРЕНИЕ КАК ФАКТОР СЕРДЕЧНО-СОСУДИСТОГО РИСКА: АКЦЕНТ НА КАЧЕСТВО И ФУНКЦИОНАЛЬНУЮ АКТИВНОСТЬ ЖИРОВОЙ ТКАНИOBESITY AS CARDIOVASCULAR RISK FACTOR: ACCENT ON QUALITY AND FUNCTIONAL ACTIVITY OF ADIPOSE TISSUEДружиловМ. А.DruzhilovM. A.

начальник терапевтического отделения стационара

drmark1982@mail.ruДружиловаО. Ю.DruzhilovaO. Yu.

врач-статистик

БетелеваЮ. Е.BetelevaYu. E.

врач ультразвуковой диагностики стационара

КузнецоваТ. Ю.KuznetsovaT. Yu.

д.м.н., зав. кафедрой факультетской терапии, фтизиатрии, инфекционных болезней и эпидемиологии медицинского института

Медико-санитарная часть УФСБ России по Республике Карелия, ПетрозаводскРоссияMedical Department of GFSS in Karelia Republic, PetrozavodskRussian FederationФГБОУ ВПО Петрозаводский государственный университет, Петрозаводск, Россия.РоссияFSBEI HPE Petrozavodsk State University, Petrozavodsk, RussiaRussian Federation20152804201504111117Copyright © Дружилов М.А., Дружилова О.Ю., Бетелева Ю.Е., Кузнецова Т.Ю., 20152015Дружилов М.А., Дружилова О.Ю., Бетелева Ю.Е., Кузнецова Т.Ю.Druzhilov M.A., Druzhilova O.Y., Beteleva Y.E., Kuznetsova T.Y.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://russjcardiol.elpub.ru/jour/article/view/296

Ожирение является одним из основных факторов сердечно-сосудистого риска. Исторически сложившееся представление о взаимосвязи ожирения с сердечно-сосудистыми заболеваниями в последние годы претерпевает изменения с учетом появляющихся результатов новых эпидемиологических и проспективных исследований.Имеющиеся в настоящее время неоспоримые доказательства являются основой критики определения и классификации ожирения, базирующейся на индексе массы тела, и заставляют обращать внимание на характер распределения жировой ткани, выраженность висцеральной жировой ткани и её функциональные характеристики. Методом, способным обеспечить, вероятно, лучшее прогнозирование кардиометаболического риска при ожирении, является использование прямых методов оценки висцеральной жировой ткани.

Obesity is one of the main cardiovascular risk factors. Recently there are significant shifts in conceptual relationships of obesity and cardiovascular diseases as there are new results of epidemiologic and prospective studies. Currently there is strict evidence for criticism of obesity definition and classification basing on body mass index that makes necessary to pay attention to the localization of adipose tissue, amount of visceral fat and its functional characteristics. Method that possibly can improve prognostic assessment of the risk in obesity is the usage of direct methods for visceral fat tissue evaluation.

исцеральное ожирениеметаболический синдромсердечно-сосудистый рискэпикардиальная жировая ткань.visceral fatmetabolic syndromecardiovascular riskepicardia adipose tissue.lReferencesPischonT, Boeing H, Hoffmann K, etal. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008; 359: 2105-20.PischonT, Boeing H, Hoffmann K, etal. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008; 359: 2105-20.Obesity and overweight. Fact sheet No. 311. http://www.who.int/mediacentre/factsheets/ fs311 (March 2013).Obesity and overweight. Fact sheet No. 311. http://www.who.int/mediacentre/factsheets/ fs311 (March 2013).Mathieu P, PoirierP, Pibarot P. Visceral obesity: the link among inflammation, hypertension, and cardiovasculardisease. Hypertension 2009; 53: 577-84.Mathieu P, PoirierP, Pibarot P. Visceral obesity: the link among inflammation, hypertension, and cardiovasculardisease. Hypertension 2009; 53: 577-84.Whitlock G, Lewington S, Sherliker P. Body-mass index and cause-specific mortality in 900000 adults: collaborative analyses of 57 prospective studies. Lancet 2009; 373: 1083-96.Whitlock G, Lewington S, Sherliker P. Body-mass index and cause-specific mortality in 900000 adults: collaborative analyses of 57 prospective studies. Lancet 2009; 373: 1083-96.Flegal K, Kit B, Orpana H, et al. Association of all-cause mortality with overweight and obesity using standard body mass index categories. JAMA 2013; 309(1): 71-82.Flegal K, Kit B, Orpana H, et al. Association of all-cause mortality with overweight and obesity using standard body mass index categories. JAMA 2013; 309(1): 71-82.BluherM. Are there still healthy obese patients? Curr Opin Endocrinol Diabetes Obes 2012; 19:341-6.BluherM. Are there still healthy obese patients? Curr Opin Endocrinol Diabetes Obes 2012; 19:341-6.Poirier R Giles T, BrayG. Obesity, cardiovascular disease: pathophysiology, evaluation, effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006; 113: 898-918.Poirier R Giles T, BrayG. Obesity, cardiovascular disease: pathophysiology, evaluation, effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006; 113: 898-918.Okorodudu D, JumeanM, MontoriV, et al. Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes 2010; 34: 791-9.Okorodudu D, JumeanM, MontoriV, et al. Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes 2010; 34: 791-9.Kennedy A, Shea J, Sun G. Comparison of the classification of obesity by BMI vs. dual-energy X-ray absorptiometry in the Newfoundland population. Obesity (Silver Spring) 2009; 17: 2094-9.Kennedy A, Shea J, Sun G. Comparison of the classification of obesity by BMI vs. dual-energy X-ray absorptiometry in the Newfoundland population. Obesity (Silver Spring) 2009; 17: 2094-9.Romero-Corral A, Somers V, Sierra-Johnson J, et al. Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J 2010; 31: 737-46.Romero-Corral A, Somers V, Sierra-Johnson J, et al. Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J 2010; 31: 737-46.Karelis A, St-Pierre D, Conus R et al. Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 2004; 89: 2569-75.Karelis A, St-Pierre D, Conus R et al. Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 2004; 89: 2569-75.Yusuf S, Hawken S, Ounpuu S, et al. INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005; 366: 1640-9.Yusuf S, Hawken S, Ounpuu S, et al. INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005; 366: 1640-9.Coutinho T Goel K, Correa de Sa D, et al. Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data. J Am Coll Cardiol 2011; 57:1877-86.Coutinho T Goel K, Correa de Sa D, et al. Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data. J Am Coll Cardiol 2011; 57:1877-86.De Koning L, Merchant A, PogueJ. Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J 2007; 28: 850-6.De Koning L, Merchant A, PogueJ. Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J 2007; 28: 850-6.Alberti K, Eckel R, Grundy S, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association forthe study of obesity. Circulation 2009; 120:1640-5.Alberti K, Eckel R, Grundy S, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association forthe study of obesity. Circulation 2009; 120:1640-5.Klein S, Allison D, Heymsfield S. Waist circumference and cardiometabolic risk: a consensus statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Am J Clin Nutr2007; 85(5): 1197-202.Klein S, Allison D, Heymsfield S. Waist circumference and cardiometabolic risk: a consensus statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Am J Clin Nutr2007; 85(5): 1197-202.Ardern C, Janssen I, Ross R. Development of healthrelated waist circumference thresholds within BMI categories. Obes Res 2004; 12: 1094-103.Ardern C, Janssen I, Ross R. Development of healthrelated waist circumference thresholds within BMI categories. Obes Res 2004; 12: 1094-103.Bastien M, PoirierP, Lemieuxl, etal. Overview of Epidemiology and Contribution of Obesity to Cardiovascular Disease. Progress in Cardiovascular Diseases 2014; 54(4): 369-81.Bastien M, PoirierP, Lemieuxl, etal. Overview of Epidemiology and Contribution of Obesity to Cardiovascular Disease. Progress in Cardiovascular Diseases 2014; 54(4): 369-81.Hajer G, Haeften T, Visseren F. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. European Heart Journal 2008; 29: 2959-71.Hajer G, Haeften T, Visseren F. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. European Heart Journal 2008; 29: 2959-71.Sun K, Kusminski C, Scherer P. Adipose tissue remodeling and obesity. J Clin Invest 2011; 121(6):2094-101.Sun K, Kusminski C, Scherer P. Adipose tissue remodeling and obesity. J Clin Invest 2011; 121(6):2094-101.lacobellis G, Willens H. Echocardiographic epicardial fat: a review of research and clinical applications. J Am Soc Echocardiogr2009; 23:1311-9.lacobellis G, Willens H. Echocardiographic epicardial fat: a review of research and clinical applications. J Am Soc Echocardiogr2009; 23:1311-9.Despres J, Lemieux I, Bergeron J, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vase Biol 2008;28:1039-49.Despres J, Lemieux I, Bergeron J, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vase Biol 2008;28:1039-49.Chumakova GA, Veselovskaya NG, Kozarenko AA. Heart morphology, structure, and function in obesity. Russ J Cardiol 2012, 4(96): 93-9. Russian (Г.А.Чумакова, Н.Г. Веселовская, А.А. Козаренко. Особенности морфологии, структуры и функции сердца при ожирении. Российский кардиологический журнал 2012; 4(96): 93-9).Chumakova GA, Veselovskaya NG, Kozarenko AA. Heart morphology, structure, and function in obesity. Russ J Cardiol 2012, 4(96): 93-9. Russian (Г.А.Чумакова, Н.Г. Веселовская, А.А. Козаренко. Особенности морфологии, структуры и функции сердца при ожирении. Российский кардиологический журнал 2012; 4(96): 93-9).Despres J. Body Fat Distribution and Risk of Cardiovascular Disease: An Update. Circulation 2012; 126:1301-13.Despres J. Body Fat Distribution and Risk of Cardiovascular Disease: An Update. Circulation 2012; 126:1301-13.Chumakova GA, Veselovskaya NG, Gritsenko OV, et al. Epicardial obesity as a possible marker of metabolic syndrome. Kardiosomatika 2012; 4: 51-4. Russian (Чумакова Г.А., Веселовская Н.Г, ГриценкоО.В. и др. Эпикардиальное ожирение как возможный маркер метаболического синдрома. Кардиосоматика 2012; 4: 51-4).Chumakova GA, Veselovskaya NG, Gritsenko OV, et al. Epicardial obesity as a possible marker of metabolic syndrome. Kardiosomatika 2012; 4: 51-4. Russian (Чумакова Г.А., Веселовская Н.Г, ГриценкоО.В. и др. Эпикардиальное ожирение как возможный маркер метаболического синдрома. Кардиосоматика 2012; 4: 51-4).Druzhilov MA, Beteleva YuE, Kuznetsova TYu. Epicardial adipose tissue thickness — an alternative to waist circumference as a stand-alone or secondary main criterion in metabolic syndrome diagnostics? Russ J Cardiol 2014; 3(107): 76-81. Russian (M.A. Дружилов, Ю.Е. Бетелева, Т.Ю. Кузнецова. Толщина эпикардиальногожира — альтернатива окружности талии как самостоятельный или второй основной критерий для диагностики метаболического синдрома? Российский кардиологический журнал 2014; 3(107): 76-81).Druzhilov MA, Beteleva YuE, Kuznetsova TYu. Epicardial adipose tissue thickness — an alternative to waist circumference as a stand-alone or secondary main criterion in metabolic syndrome diagnostics? Russ J Cardiol 2014; 3(107): 76-81. Russian (M.A. Дружилов, Ю.Е. Бетелева, Т.Ю. Кузнецова. Толщина эпикардиальногожира — альтернатива окружности талии как самостоятельный или второй основной критерий для диагностики метаболического синдрома? Российский кардиологический журнал 2014; 3(107): 76-81).Gastaldelli A, Basta G. Ectopicfat and cardiovascular disease: what is the link. Nutr Metab CardiovascDis2010; 20:481-90.Gastaldelli A, Basta G. Ectopicfat and cardiovascular disease: what is the link. Nutr Metab CardiovascDis2010; 20:481-90.Britton K, FoxC. Ectopic fat depots and cardiovascular disease. Circulation 2011; 124: 837-41.Britton K, FoxC. Ectopic fat depots and cardiovascular disease. Circulation 2011; 124: 837-41.Morelli M, Gaggini M, Daniele G, et al. Ectopic fat: the true culprit linking obesity and cardiovascular disease? Thromb Haemost 2013; 110:651-60.Morelli M, Gaggini M, Daniele G, et al. Ectopic fat: the true culprit linking obesity and cardiovascular disease? Thromb Haemost 2013; 110:651-60.lacobellis G, Assael F, Ribaudo M, et al. Epicardial Fat from Echocardiography: a New Method for Visceral Adipose Tissue Prediction. Obes Res 2003; 11:304-31.lacobellis G, Assael F, Ribaudo M, et al. Epicardial Fat from Echocardiography: a New Method for Visceral Adipose Tissue Prediction. Obes Res 2003; 11:304-31.Chumakova GA, Veselovskaya NG, Kozarenko AA. Epicardial fat depot: morphology, diagnosis, clinical significance. Heart 2011; 3(59): 143-7. Russian (Чумакова Г. А., Веселовская Н.Г, Козаренко А.А. Эпикардиальное жировое депо: морфология, диагностика, клиническое значение Сердце 2011; 3(59): 143-7).Chumakova GA, Veselovskaya NG, Kozarenko AA. Epicardial fat depot: morphology, diagnosis, clinical significance. Heart 2011; 3(59): 143-7. Russian (Чумакова Г. А., Веселовская Н.Г, Козаренко А.А. Эпикардиальное жировое депо: морфология, диагностика, клиническое значение Сердце 2011; 3(59): 143-7).Silaghi A, Piercecchi-Marti M, Grino M, et al. Epicardial adipose tissue extent: relationship with age, body fat distribution, and coronaropathy. Obesity 2008; 16: 2424-30.Silaghi A, Piercecchi-Marti M, Grino M, et al. Epicardial adipose tissue extent: relationship with age, body fat distribution, and coronaropathy. Obesity 2008; 16: 2424-30.WillensH., Goinez-Marin 0., ChirinosJ. et al. Comparison of epicardial and pericardial fat thickness assessed by echocardiography in African American and non-Hispanic White men: a pilot study. Ethn Dis 2008; 18(3): 311-6.WillensH., Goinez-Marin 0., ChirinosJ. et al. Comparison of epicardial and pericardial fat thickness assessed by echocardiography in African American and non-Hispanic White men: a pilot study. Ethn Dis 2008; 18(3): 311-6.Druzhilov MA, Otmakhov W, Beteleva YuE, et al. Epicardial fat pad and rates of cardiovascular remodeling in normotensive patients with abdominal obesity. Serdechnaja nedostatochnost' 2013; 14(1): 22-8. Russian (Дружилов M.A., Отмахов В. В., Бетелева Ю. Е. и др. Эпикардиальный жир и показатели кардиоваску-лярного ремоделирования у нормотензивных пациентов с абдоминальным ожирением. Сердечная недостаточность 2013; 14(1): 22-8).Druzhilov MA, Otmakhov W, Beteleva YuE, et al. Epicardial fat pad and rates of cardiovascular remodeling in normotensive patients with abdominal obesity. Serdechnaja nedostatochnost' 2013; 14(1): 22-8. Russian (Дружилов M.A., Отмахов В. В., Бетелева Ю. Е. и др. Эпикардиальный жир и показатели кардиоваску-лярного ремоделирования у нормотензивных пациентов с абдоминальным ожирением. Сердечная недостаточность 2013; 14(1): 22-8).Natale F, Tedesco M, Mocerino R, et al. Visceral adiposity and arterial stiffness: echocardiographic epicardial fat thickness reflects, better than waist circumference, carotid arterial stiffness in a large population of hypertensives. Eur J Echocardiogr 2009; 10:549-55.Natale F, Tedesco M, Mocerino R, et al. Visceral adiposity and arterial stiffness: echocardiographic epicardial fat thickness reflects, better than waist circumference, carotid arterial stiffness in a large population of hypertensives. Eur J Echocardiogr 2009; 10:549-55.MaglianoC, NascimentoC,CastelliR,etal. Epicardial Fat Measured to the Echocardiogram is correlated to Carotid Atheromathosis. Rev bras ecocardiogr imagem cardiovasc 2011; 24(2): 16-22.MaglianoC, NascimentoC,CastelliR,etal. Epicardial Fat Measured to the Echocardiogram is correlated to Carotid Atheromathosis. Rev bras ecocardiogr imagem cardiovasc 2011; 24(2): 16-22.Nelson M, Mookadam F, ThotaV. Fat: An Additional Measurement for Subclinical Atherosclerosis and Cardiovascular Risk Stratification. J Am Soc Echocardiogr 2011; 24(3):339-45.Nelson M, Mookadam F, ThotaV. Fat: An Additional Measurement for Subclinical Atherosclerosis and Cardiovascular Risk Stratification. J Am Soc Echocardiogr 2011; 24(3):339-45.Druzhilov MA, Otmakhov W, Kuznetsova TYu. Role of epicardial fat thickness determined by echocardiographic method in patients with metabolic syndrome. Clinico-laboratorniy consilium 2014; 3-4(50): 32-7. Russian (Дружилов М. А., Отмахов В. В., Кузнецова Т. Ю. Значение эхокардиографически определяемой толщины эпикардиальногожира при метаболическом синдроме. Клинико-лабораторный консилиум 2014; 3-4(50): 32-7).Druzhilov MA, Otmakhov W, Kuznetsova TYu. Role of epicardial fat thickness determined by echocardiographic method in patients with metabolic syndrome. Clinico-laboratorniy consilium 2014; 3-4(50): 32-7. Russian (Дружилов М. А., Отмахов В. В., Кузнецова Т. Ю. Значение эхокардиографически определяемой толщины эпикардиальногожира при метаболическом синдроме. Клинико-лабораторный консилиум 2014; 3-4(50): 32-7).The consensus of experts on a multidisciplinary approach to the management, diagnosis and treatment of patients with metabolic syndrome. Cardiovascular Therapy and Prevention 2013; 12(6): 41-81. Russian (Консенсус экспертов по междисциплинарному подходу к ведению, диагностике и лечению больных с метаболическим синдромом. Кардиоваскулярная терапия и профилактика 2013; 12(6): 41-81).The consensus of experts on a multidisciplinary approach to the management, diagnosis and treatment of patients with metabolic syndrome. Cardiovascular Therapy and Prevention 2013; 12(6): 41-81. Russian (Консенсус экспертов по междисциплинарному подходу к ведению, диагностике и лечению больных с метаболическим синдромом. Кардиоваскулярная терапия и профилактика 2013; 12(6): 41-81).Chaowalit N, Lopez-Jimenez F Epicardial adipose tissue: friendly companion or hazardous neighbour for adjacent coronary arteries? European Heart Journal 2008; 29: 695-7.Chaowalit N, Lopez-Jimenez F Epicardial adipose tissue: friendly companion or hazardous neighbour for adjacent coronary arteries? European Heart Journal 2008; 29: 695-7.Zhang H, Zhang С Regulation of microvascular function by adipose tissue in obesity and type 2 diabetes: evidence of an adipose-vascular loop. Am J Biomed Sci 2009; 1: 133-42.Zhang H, Zhang С Regulation of microvascular function by adipose tissue in obesity and type 2 diabetes: evidence of an adipose-vascular loop. Am J Biomed Sci 2009; 1: 133-42.Chumakova GA, Veselovskaya NG, Gritsenko OV, et al. Epicardial obesity as risk factor for coronary atherosclerosis. Cardiology 2013; 1:51-5. Russian (Чумакова Г A., Веселовская Н.Г, ГриценкоО.В. и др. Эпикардиальное ожирение как фактор риска развития коронарного атеросклероза. Кардиология 2013; 1:51 -5).Chumakova GA, Veselovskaya NG, Gritsenko OV, et al. Epicardial obesity as risk factor for coronary atherosclerosis. Cardiology 2013; 1:51-5. Russian (Чумакова Г A., Веселовская Н.Г, ГриценкоО.В. и др. Эпикардиальное ожирение как фактор риска развития коронарного атеросклероза. Кардиология 2013; 1:51 -5).Veselovskaya NG, Chumakova GA, Elykomov VA, et al. Risk factors for restenosis after coronary stenting in patients with obesity. Cardiovascular Therapy and Prevention 2013; 12(3): 4-9. Russian (Веселовская Н.Г, Чумакова ГА., Елыкомов В.А. и др. Факторы риска рестеноза после коронарного стентирования у пациентов с ожирением. Кардиоваскулярная терапия и профилактика 2013; 12(3): 4-9).Veselovskaya NG, Chumakova GA, Elykomov VA, et al. Risk factors for restenosis after coronary stenting in patients with obesity. Cardiovascular Therapy and Prevention 2013; 12(3): 4-9. Russian (Веселовская Н.Г, Чумакова ГА., Елыкомов В.А. и др. Факторы риска рестеноза после коронарного стентирования у пациентов с ожирением. Кардиоваскулярная терапия и профилактика 2013; 12(3): 4-9).Mahabadi A, Berg M, Lehmann N, et al. Association of Epicardial Fat With Cardiovascular Risk Factors and Incident Myocardial Infarction in the General Population. The Heinz Nixdorf Recall Study. J Am Coll Cardiol 2013; 61 (13): 1388-95.Mahabadi A, Berg M, Lehmann N, et al. Association of Epicardial Fat With Cardiovascular Risk Factors and Incident Myocardial Infarction in the General Population. The Heinz Nixdorf Recall Study. J Am Coll Cardiol 2013; 61 (13): 1388-95.Boytsov SA, Karpov YuA, Kukharchuk W, et al. Identification of Patients at High Cardiovascular Risk: Problems and Possible Solutions. Ateroskleroz i Dislipidemii 2010; 1(1): 9-14. Russian (Бойцов С.А., Карпов Ю.А., КухарчукВ. В. и др. Проблемы выявления лиц с высоким сердечно-сосудистым риском и возможные пути их решения. Атеросклероз и дислипидемии 2010; 1(1): 8-14).Boytsov SA, Karpov YuA, Kukharchuk W, et al. Identification of Patients at High Cardiovascular Risk: Problems and Possible Solutions. Ateroskleroz i Dislipidemii 2010; 1(1): 9-14. Russian (Бойцов С.А., Карпов Ю.А., КухарчукВ. В. и др. Проблемы выявления лиц с высоким сердечно-сосудистым риском и возможные пути их решения. Атеросклероз и дислипидемии 2010; 1(1): 8-14).

The authors declare that there are no conflicts of interest present.